Mark L Baum Harrow Health, Inc. (HROW) insider trading activity

Mark L Baum is Chief Executive Officer of HARROW HEALTH, INC.. Currently has a direct ownership of 2.6 Million shares of HROW, which is worth approximately $63.5 Million. The most recent transaction as insider was on Apr 07, 2025, when has been sold 300,363 shares (Common Stock) at a price of $23.09 per share, resulting in proceeds of $6,935,381. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 2.6M

21.61% 3M change

21.61% 12M change

Total Value Held $63.5 Million

MARK L BAUM Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Apr 07 2025	SELL Payment of exercise price or tax liability	$6,935,381 $23.09 p/Share	300,363 Reduced 10.36%	2,599,462 Common Stock
Apr 03 2025	BUY Exercise of conversion of derivative security	-	762,300 Added 20.82%	2,899,825 Common Stock
Mar 22 2024	BUY Open market or private purchase	$104,310 $11.59 p/Share	9,000 Added 0.42%	2,137,525 Common Stock
Feb 20 2024	SELL Exercise of conversion of derivative security	$638,450 $10.67 p/Share	59,836 Reduced 2.73%	2,128,525 Common Stock
Feb 20 2024	BUY Exercise of conversion of derivative security	$1,600,500 $10.67 p/Share	150,000 Added 6.41%	2,188,361 Common Stock
Feb 07 2024	BUY Exercise of conversion of derivative security	$118,734 $7.71 p/Share	15,400 Added 0.75%	2,038,361 Common Stock
Nov 16 2023	BUY Open market or private purchase	$60,824 $8.11 p/Share	7,500 Added 0.37%	2,022,961 Common Stock
Aug 14 2023	BUY Open market or private purchase	$98,890 $17.05 p/Share	5,800 Added 0.29%	2,015,461 Common Stock
Jul 18 2023	SELL Payment of exercise price or tax liability	$5,468,416 $18.23 p/Share	299,968 Reduced 12.99%	2,009,661 Common Stock
Jul 18 2023	BUY Exercise of conversion of derivative security	-	762,300 Added 24.82%	2,309,629 Common Stock
Apr 03 2023	SELL Payment of exercise price or tax liability	$2,466,764 $20.97 p/Share	117,633 Reduced 7.07%	1,547,329 Common Stock
Apr 03 2023	BUY Exercise of conversion of derivative security	$1,618,200 $8.99 p/Share	180,000 Added 9.76%	1,664,962 Common Stock
Jan 02 2023	SELL Payment of exercise price or tax liability	$519,242 $14.76 p/Share	35,179 Reduced 2.31%	1,484,962 Common Stock
Jan 02 2023	BUY Exercise of conversion of derivative security	-	88,000 Added 5.47%	1,520,141 Common Stock
Dec 22 2022	BUY Open market or private purchase	$334,750 $13.39 p/Share	25,000 Added 1.72%	1,432,141 Common Stock
Jan 20 2022	SELL Payment of exercise price or tax liability	$594,812 $8.33 p/Share	71,406 Reduced 4.83%	1,407,141 Common Stock
Jan 20 2022	BUY Exercise of conversion of derivative security	$300,000 $2.4 p/Share	125,000 Added 7.8%	1,478,547 Common Stock
Apr 25 2021	SELL Payment of exercise price or tax liability	$2,759,906 $8.26 p/Share	334,129 Reduced 19.8%	1,353,547 Common Stock
Apr 25 2021	BUY Exercise of conversion of derivative security	-	850,000 Added 33.5%	1,687,676 Common Stock
Feb 25 2021	BUY Exercise of conversion of derivative security	-	200,000 Added 19.27%	837,676 Common Stock

MLB

Mark L Baum

Chief Executive Officer

Nashville, TN

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells HROW shares.

Notify only if

Value

Insider Trading

Get notified when an Harrow Health, Inc. insider buys or sells HROW shares.

Notify only if

Operation

Value

Type

News

Receive news related to HARROW HEALTH, INC.

Track Activities on HROW

Account